Significance of plasma lysolecithin in patients with multiple sclerosis: a longitudinal study
AUTOR(ES)
Andreoli, V. M.
RESUMO
Five patients with multiple sclerosis and four normal subjects have been followed for over two years. Plasma phospholipid levels and phospholipid fatty acid composition have been assayed periodically. The increased amount of plasma lysolecithin already described by us has been confirmed in this longitudinal study. A significant increase in saturated fatty acids of lysolecithin has also been demonstrated. In contrast, the lecithin concentration and fatty acid composition do not show any significant variations. The lysolecithin saturated/unsaturated fatty acid ratio was different in the same patients at different times, but no correlation was established between these variations and the clinical symptoms measured using the Kurtzke scale. The possible significance of saturated fatty acid increase in lysolecithin in the pathogenetic mechanisms of multiple sclerosis is discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=494425Documentos Relacionados
- Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients.
- The natural history of multiple sclerosis: a regional study with some longitudinal data.
- Follow-up of patients with suspected multiple sclerosis: a clinical and electrophysiological study.
- The prevalence of bruxism and related factors in patients with multiple sclerosis: a comparative study
- Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.
